Preferred Sample Type

Calcitonin

Suitable Specimen Types

  • Serum
5 mL blood

Specimen Transport

Serum must be transported to referral laboratory frozen.

Sample Processing in Laboratory

On ice to laboratory immediately. Separate within 30 mins of collection in a cooled centrifuge. Freeze the serum and transport to SAS centre frozen.

Sample Preparation

Collect blood into a plain (red top) vacutainer placed on ice. Transport to lab on ice immediately. Separate within 30 mins of collection in a cooled centrifuge.

Turnaround Time

7 days - assayed 3 times /week

Sample Stability

-20 ºC

Calcitonin

General Information

Calcitonin is a peptide hormone secreted by the parafollicular C-cells of the thyroid under calcium control. Its precise physiological function is poorly understood.

The main use of serum calcitonin is in the diagnosis and monitoring of medullary carcinoma of the thyroid. In those cases which are of familial origin (MEN II), serum calcitonin can also be used as a screening test in the relatives of known cases.

Inappropriate secretion of calcitonin may also be seen in a variety of other neoplasms, including small cell carcinoma of lung, breast carcinoma, renal tubular carcinoma and carcinoid tumours.

Moderate increases may be seen in pregnancy, renal failure and pernicious anaemia.

Patient Preparation

Fasting samples are recommended by referral laboratory (Medical Oncology, Charing Cross) however samples will still be analysed if the patient is not fasted.

Notes

Tests which attempt to stimulate the levels of calcitonin are more sensitive than calcitonin measurements alone. These tests involve collecting a sample before stimulation, then giving the patient an injection of intravenous calcium and/or pentagastrin to stimulate calcitonin production. Several more blood samples are then collected over the next few minutes to gauge the effect of the stimulation. Patients with early C-cell hyperplasia and/or MTC will usually have very significant increases in their levels of calcitonin during this test.

Stimulation tests may also be used when a patient has indeterminate or normal calcitonin results but clinical suspicions remain.

Reference Range

Females <5.5 ng/L
Males < 18.9 ng/L
(New reference range July 2006 - Diasorin assay)

Specifications

  • EQA Status: No details

Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018

HTA licence number is 12366

Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.

The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS HEFT